Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

Healthcare AI today: Docs and clerks, talk therapy renewed, Dr. AI vs. Dr. Google, more
Not long ago, physicians and grocery clerks had a key duty in common: ‘connective labor.’ Today barcode reading machines sweep you through the checkout. And AI can handle most of your health questions.
Healthcare AI today: Rusty clinical skills, AI growing up so fast, AI for the malnourished
Clinicians who come to rely on AI for decision support risk the dulling of their skills. The concern is not new. But now comes a pointed call to researchers: Inquire about the particulars of the peril.
Which LLM is best for explaining radiology results?
With patients gaining access to imaging reports earlier than ever, it's critical they have access to large language models that can accurately summarize the results.
More good news for renal denervation: FDA-approved systems linked to positive long-term data
New data on the RDN systems from Recor Medical and Medtronic confirmed that this relatively new technology brings long-term relief to patients with uncontrolled hypertension.
First-in-human data highlight IVL’s potential to treat more challenging lesions
Shockwave Medical and FastWave Medical have shared new first-in-human data on their advanced IVL offerings. Both companies are focused on addressing difficult-to-cross lesions that often cause problems for cardiologists.

Medtronic has received U.S. Food and Drug Administration (FDA) approval for its Evolut FX+ transcatheter aortic valve replacement (TAVR) system for the treatment of symptomatic severe aortic stenosis.

FDA approves Medtronic’s next-generation TAVR system with new frame design

The Evolut FX+ TAVR system includes an updated diamond-shaped frame, which was made four times larger than previous models to offer improved coronary access. It was also designed to provide more space for operators to guide and maneuver the catheter during procedures.

Industry Watcher’s Digest

Buzzworthy developments of the past few days.

5 tips on AI adoption from a frontline physician champion

AI adoption for real-world healthcare settings can’t happen in a vacuum.

artificial intelligence robot evaluates healthcare data

New data registry will track how AI-powered plaque assessments impact cardiologist decisions

HeartFlow hopes to gather real-world data from up to 10,000 patients with suspected CAD.

Newsweek ranked the 50 best heart hospitals in the world

Hospital accused of implanting experimental heart valve in young patient without proper consent

Members of Congress are now asking the FDA to investigate a parent's claim that her 14-year-old son was treated with an experimental heart valve without proper consent. The valve eventually failed and had to be replaced. The hospital has said its heart team did nothing wrong.

‘Allyship’ needed between nurses and MDs to take on workforce crisis

“Most health systems rely on a financial cost-containment model to inform staffing decisions. Clinicians understand the patient populations and needs over time, yet they are currently excluded from most staffing decisions,” the authors write.

Industry Watcher’s Digest

Buzzworthy developments of the past few days.

artificial intelligence for family medicine primary care

Large language AI put to the test for potential adopters in primary care

ChatGPT is only so-so at letting physicians know if any given clinical study is relevant to their patient rosters and, as such, deserving of a full, time-consuming read. On the other hand ...

Care Delivery

Healthcare AI today: Docs and clerks, talk therapy renewed, Dr. AI vs. Dr. Google, more

Healthcare AI today: Rusty clinical skills, AI growing up so fast, AI for the malnourished

Which LLM is best for explaining radiology results?

More good news for renal denervation: FDA-approved systems linked to positive long-term data

First-in-human data highlight IVL’s potential to treat more challenging lesions